Investor Relations

(Security Code :4506 TSE Prime)

Pick Up

Oct. 30, 2026	Presentation Material (Conference on Q2 FY2026 Financial Results )（PDF/1,061KB）	Finances
Oct. 30, 2026	Supplementary Financial Data (IFRS) for the Six Months Ended September 30, 2026（PDF/392KB）	Finances
Oct. 30, 2026	Summary of Consolidated Financial Results for the Six Months Ended September 30, 2026 [IFRS]（PDF/431KB）	Finances
Oct. 30, 2026	Sumitomo Pharma Announces Variances Between Consolidated Financial Forecasts and Actual Results for the Six Months Ended September 30, 2026 and Revisions to Consolidated Financial Forecasts for the Fiscal Year Ending March 31, 2027	Finances
Oct. 30, 2026	Sumitomo Pharma Announces Revision of Its Year-End Dividend Forecast for the Fiscal Year Ending March 31, 2027	Finances
Oct. 29, 2026	Posted Integrated Report 2026	Others

Oct. 30, 2026	2nd Quarter of FY2026 financial results announcement (scheduled to be disclosed at 3:30 p.m.), conference on 2nd quarter FY2026 financial results for Analysts, Investors, and the Press